Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Geneva, Switzerland
SEC filing record 1 source field available
Fiscal year end
31 December
Addex Therapeutics Ltd. has filed 274 SEC EDGAR filings since 24 Sep 2019

SEC filing history

Showing 26-50 of 274 matching filings.

Per page
25
Current page
2
3

OWNERSHIP DOCUMENT

Filing date
25 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
18 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
18 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
18 Mar 2026
Reporting date
18 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
03 Feb 2026
Reporting date
03 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
07 Jan 2026
Reporting date
07 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
10 Dec 2025
Reporting date
10 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-291644

424B5

Filing date
10 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-291644

EFFECT filing

Filing date
05 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
04 Dec 2025
Reporting date
04 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
29 Oct 2025
Reporting date
29 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
23 Sep 2025
Reporting date
23 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
30 Jun 2025
Reporting date
30 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
25 Jun 2025
Reporting date
25 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-91805

SCHEDULE 13D/A filing

Filing date
23 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
20 Jun 2025
Reporting date
20 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
06 Jun 2025
Reporting date
06 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
12 May 2025
Reporting date
12 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 20-F File 001-39179

NT 20-F

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
30 Apr 2025
Reporting date
30 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
25 Apr 2025
Reporting date
25 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .